abstract |
A pharmaceutical composition for oral use, in particular a tablet, the active ingredient of which contains a pharmacologically acceptable salt of dichloromethylene diphosphonic acid, i.e. clodronate, in particular disodium clodronate, and which contains as carrier microcrystalline cellulose containing silicon oxide. |